We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$589M
Cap. Flow %
4.16%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Industrials 12.27%
4 Healthcare 11.72%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
201
Pultegroup
PHM
$23.7B
$21.4M 0.15%
+181,784
New +$23.3M
NHI icon
202
National Health Investors
NHI
$3.93B
$20.9M 0.15%
258,023
-28,332
-10% -$2.36M
CTAS icon
203
Cintas
CTAS
$80.2B
$20.7M 0.15%
122,608
+85,814
+233% +$16.5M
REXR icon
204
Rexford Industrial Realty
REXR
$8.38B
$20.7M 0.15%
+632,076
New +$23.7M
RDNT icon
205
RadNet
RDNT
$4.87B
$20.4M 0.14%
365,394
+184,383
+102% +$12.6M
HPQ icon
206
HP
HPQ
$22.7B
$20.4M 0.14%
+1,060,594
New +$20.6M
EPRT icon
207
Essential Properties Realty Trust
EPRT
$7.19B
$20.3M 0.14%
+669,637
New +$21.2M
DNTH icon
208
Dianthus Therapeutics
DNTH
$5.78B
$20.1M 0.14%
+239,943
New +$13.9M
VICI icon
209
VICI Properties
VICI
$29.3B
$20M 0.14%
+731,781
New +$20.9M
ONTO icon
210
Onto Innovation
ONTO
$14.9B
$19.8M 0.14%
+96,509
New +$19.8M
THC icon
211
Tenet Healthcare
THC
$16.9B
$19.7M 0.14%
+104,187
New +$22M
ANIP icon
212
ANI Pharmaceuticals
ANIP
$1.8B
$19.6M 0.14%
254,230
+113,121
+80% +$8.83M
TSCO icon
213
Tractor Supply
TSCO
$15.5B
$19.5M 0.14%
+429,422
New +$21.9M
RAL
214
Ralliant Corp
RAL
$7.95B
$19.2M 0.14%
462,361
+111,001
+32% +$5.22M
OKTA icon
215
Okta
OKTA
$24.6B
$19.2M 0.14%
244,206
-602,818
-71% -$50M
MSCI icon
216
MSCI
MSCI
$40.9B
$19.2M 0.14%
35,595
+32,691
+1,126% +$18.4M
JKHY icon
217
Jack Henry & Associates
JKHY
$10.6B
$19.2M 0.14%
+121,400
New +$20.8M
LECO icon
218
Lincoln Electric
LECO
$13.6B
$18.6M 0.13%
74,808
+16,154
+28% +$4.32M
OSCR icon
219
Oscar Health
OSCR
$9.28B
$18.4M 0.13%
1,602,569
+1,093,633
+215% +$15.4M
GLNG icon
220
Golar LNG
GLNG
$5.06B
$18.3M 0.13%
338,908
+184,234
+119% +$8.13M
LRCX icon
221
Lam Research
LRCX
$403B
$18.1M 0.13%
84,644
-7,078
-8% -$1.58M
AAPL icon
222
Apple
AAPL
$4.81T
$18M 0.13%
+70,839
New +$18.4M
BOOT icon
223
Boot Barn
BOOT
$4.52B
$17.9M 0.13%
+122,331
New +$22.2M
KALV
224
DELISTED
KalVista Pharmaceuticals
KALV
$17.8M 0.13%
882,906
+249,887
+39% +$4.03M
BRZE icon
225
Braze
BRZE
$2.73B
$17.8M 0.13%
752,747
+318,637
+73% +$6.89M

Similar funds

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.